MiR‐6838‐5p suppresses cell metastasis and the EMT process in triple‐negative breast cancer by targeting WNT3A to inhibit the Wnt pathway

MicroRNA-140-5p inhibits cell proliferation, migration and promotes cell apoptosis in gastric cancer through the negative regulation of THY1-mediated Notch signaling

(2019) Kun Wu et al.   BIOSCIENCE REPORTS

A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer

(2019) Kai Li et al.   PATHOLOGY RESEARCH AND PRACTICE

TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells

(2019) Jian Wu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Targeting of G-Quadruplex Harboring Pre-miRNA 92b by LNA Rescues PTEN Expression in NSCL Cancer Cells

(2018) Gayan Mirihana Arachchilage et al.   ACS Chemical Biology

MiRNA-20a-5p promotes the growth of triple-negative breast cancer cells through targeting RUNX3

(2018) Xiangdong Bai et al.   BIOMEDICINE & PHARMACOTHERAPY

Combination of three miRNA (miR-141, miR-21, and miR-375) as potential diagnostic tool for prostate cancer recognition

(2018) Paweł Porzycki et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Effects of Kanglaite Injection on Serum miRNA-21 in Patients with Advanced Lung Cancer

(2018) Yue Wu et al.   MEDICAL SCIENCE MONITOR

Label-free ultrasensitive detection of breast cancer miRNA-21 biomarker employing electrochemical nano-genosensor based on sandwiched AgNPs in PANI and N-doped graphene

(2018) Razieh Salahandish et al.   BIOSENSORS & BIOELECTRONICS

Serum levels of circulating miRNA-21, miRNA-10b and miRNA-200c in triple-negative breast cancer patients

(2018) Sebastian Niedźwiecki et al.   Ginekologia Polska

Molecular pathogenesis of triple-negative breast cancer based on microRNA expression signatures: antitumor miR-204-5p targets AP1S3

(2018) Hiroko Toda et al.   JOURNAL OF HUMAN GENETICS

Phosphodiesterase 7B/microRNA-200c relationship regulates triple-negative breast cancer cell growth

(2018) Dan-Dan Zhang et al.   ONCOGENE

Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts

(2018) Yuan Zhou et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies

(2017) Mary Kathryn Pitner et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer

(2017) Ying Zeng et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

EMT and inflammation: inseparable actors of cancer progression

(2017) Meggy Suarez-Carmona et al.   Molecular Oncology

The diagnostic role of plasma circulating precursors of miRNA-944 and miRNA-3662 for non-small cell lung cancer detection

(2017) Tomasz Powrózek et al.   PATHOLOGY RESEARCH AND PRACTICE

Potential therapeutic targets of triple-negative breast cancer based on its intrinsic subtype

(2017) Fangyuan Shao et al.   Oncotarget

Effect of miRNA-203 on cervical cancer cells and its underlying mechanism

(2016) X.Z. Yin et al.   GENETICS AND MOLECULAR RESEARCH

Outcomes of Triple-Negative Breast Cancers (TNBC) Compared with Non-TNBC: Does the Survival Vary for All Stages?

(2016) Gaurav Agarwal et al.   WORLD JOURNAL OF SURGERY

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer

(2016) Jingdan Qiu et al.   Journal of Cancer

The predictive value and potential mechanisms of miRNA-328 and miRNA-378 for brain metastases in operable and advanced non-small-cell lung cancer

(2015) D. Sun et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Editorial (Thematic Issue: “miRNA and Cancer; Computational and Experimental Approaches”)

(2014) Yusuf Tutar   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Triple-Negative Breast Cancer

(2010) Shaheenah Dawood   DRUGS